物质使用障碍与脑肿瘤患者术后再入院独立相关
单中心2017年1月1日至2019年12月31日共2519例脑肿瘤手术患者中124例(4.9%)存在至少1种物质使用障碍,双变量分析显示仅90天再入院与之显著相关(比值比2.21,P=0.0011),多变量校正后仍独立相关(比值比1.82,P=0.013)。
要点
- 脑肿瘤手术患者中物质使用障碍患病率为4.9%(124/2519),其中酒精使用障碍90例(3.6%)。
- 双变量分析中90天再入院是唯一与物质使用障碍显著相关的术后结局(比值比2.21,P=0.0011)。
- 校正年龄、性别、种族、婚姻状况、保险、肿瘤诊断、5因子改良衰弱指数评分、美国麻醉医师协会评分及手术次数后,物质使用障碍仍独立预测90天再入院(比值比1.82,P=0.013)。
核心结论
- 在脑肿瘤患者中,物质使用障碍显著且独立预测术后90天再入院。
- 作者认为术前和术后对物质使用障碍患者进行针对性管理可优化患者结局并改善高价值神经外科医疗的提供。
研究设计与样本
- 单中心研究,纳入2017年1月1日至2019年12月31日期间接受脑肿瘤手术切除的患者,共2519例,其中124例(4.9%)存在至少1种物质使用障碍。
- 连续变量双变量分析采用曼-惠特尼U检验,分类变量采用费希尔精确检验,多变量分析采用逻辑回归模型。
主要发现
- 124例(4.9%)患者存在至少1种物质使用障碍,其中酒精使用障碍90例(3.6%)、大麻使用障碍27例(1.1%)、阿片类使用障碍12例(0.5%)。
- 双变量分析中,90天再入院是唯一与物质使用障碍显著相关的术后结局(比值比2.21,P=0.0011)。
- 多变量分析校正年龄、性别、种族、婚姻状况、保险、脑肿瘤诊断、5因子改良衰弱指数评分、美国麻醉医师协会评分及手术次数后,物质使用障碍仍与90天再入院显著独立相关(比值比1.82,P=0.013)。
临床怎么用
- 作者认为,术前和术后对物质使用障碍患者进行针对性管理可优化患者结局并改善高价值神经外科医疗的提供。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research on the effects of substance use disorders (SUDs) on postoperative outcomes within neurosurgical oncology has been limited. Therefore, the present study sought to quantify the effect of having a SUD on hospital length of stay, postoperative complication incidence, discharge disposition, hospital charges, 90-day readmission rates, and 90-day mortality rates following brain tumor surgery. METHODS: The present study used data from patients who received surgical resection for brain tumor at a single institution between January 1, 2017, and December 31, 2019. The Mann-Whitney U test was used for bivariate analysis of continuous variables and Fisher exact test was used for bivariate analysis of categorical variables. Multivariate analysis was conducted using logistic regression models. RESULTS: Our study cohort included a total of 2519 patients, 124 (4.9%) of whom had at least 1 SUD. More specifically, 90 (3.6%) patients had an alcohol use disorder, 27 (1.1%) had a cannabis use disorder, and 12 (0.5%) had an opioid use disorder. On bivariate analysis, 90-day hospital readmission was the only postoperative outcome significantly associated with a SUD (odds ratio 2.21, P = 0.0011). When controlling for patient age, sex, race, marital status, insurance, brain tumor diagnosis, 5-factor modified frailty index score, American Society of Anesthesiologists score, and surgery number, SUDs remained significantly and independently associated with 90-day readmission (odds ratio 1.82, P = 0.013). CONCLUSIONS: In patients with brain tumor, SUDs significantly and independently predict 90-day hospital readmission after surgery. Targeted management of patients with SUDs before and after surgery can optimize patient outcomes and improve the provision of high-value neurosurgical care.
引用
- Jimenez AE, Cicalese KV, Chakravarti S, et al. Substance Use Disorders Are Independently Associated with Hospital Readmission Among Patients with Brain Tumors. World Neurosurg. 2022. PMID: 35817348. doi:10.1016/j.wneu.2022.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。